Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 2, Pages 330-340
Publisher
Springer Nature
Online
2013-11-27
DOI
10.1038/bjc.2013.729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer
- (2015) Kristine Glunde et al. NMR IN BIOMEDICINE
- Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients
- (2015) Marina Bagnoli et al. Oncotarget
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Characterization of choline kinase in human endothelial cells
- (2013) Noriko Mori et al. NMR IN BIOMEDICINE
- Combined 5-FU and ChoKα Inhibitors as a New Alternative Therapy of Colorectal Cancer: Evidence in Human Tumor-Derived Cell Lines and Mouse Xenografts
- (2013) Ana de la Cueva et al. PLoS One
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation
- (2012) Kensaku Mizuno CELLULAR SIGNALLING
- Balance of human choline kinase isoforms is critical for cell cycle regulation
- (2012) Jens Gruber et al. FEBS Journal
- Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis
- (2012) J. D. Stewart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Targeting cancer metabolism: a therapeutic window opens
- (2011) Matthew G. Vander Heiden NATURE REVIEWS DRUG DISCOVERY
- A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling
- (2011) B F Clem et al. ONCOGENE
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Activation of Phosphatidylcholine Cycle Enzymes in Human Epithelial Ovarian Cancer Cells
- (2010) E. Iorio et al. CANCER RESEARCH
- Noninvasive Detection of Lentiviral-Mediated Choline Kinase Targeting in a Human Breast Cancer Xenograft
- (2009) B. Krishnamachary et al. CANCER RESEARCH
- Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cells
- (2009) Boon Chua et al. Molecular Cancer
- Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling
- (2009) A Yalcin et al. ONCOGENE
- Two pathways for lysophosphatidic acid production
- (2008) J AOKI BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Phosphatidylcholine-Specific Phospholipase C Activation in Epithelial Ovarian Cancer Cells
- (2008) F. Spadaro et al. CANCER RESEARCH
- Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells
- (2008) Monica Banez-Coronel et al. CURRENT CANCER DRUG TARGETS
- Gene-expression profiling in epithelial ovarian cancer
- (2008) Panagiotis A Konstantinopoulos et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search